Skip to Main Content

Paper Details

Transcriptional repression of IFNβ1 by ATF2 confers melanoma resistance to therapy.
Oncogene
19
2015
ATF2, IFN-2a, IFN1, PKC, activating transcription factor-2, early-stage melanomas, interferon-1, melanoma, melanoma tumor, metastatic melanomas, patient, protein kinase C, type-I IFN
Activating Transcription Factor 2, Cell Line, Tumor, Cell Nucleus, Down-Regulation, Drug Resistance, Neoplasm, Humans, Interferon-beta, Melanoma, Promoter Regions, Genetic, Protein Kinase C-epsilon, Signal Transduction, Transcription, Genetic
Author NameAffiliation
Eric LauCancer Center, Sanford-Burnham Medical Research Institute
John R SedyCancer Center, Sanford-Burnham Medical Research Institute
Cindy SanderUniversity of Pittsburgh Cancer Center
Misa A ShawJohn Wayne Cancer Institute
Yongmei FengCancer Center, Sanford-Burnham Medical Research Institute
Marzia ScortegagnaCancer Center, Sanford-Burnham Medical Research Institute
Giuseppina ClapsCancer Center, Sanford-Burnham Medical Research Institute
Steven E RobinsonUniversity of Colorado Anschutz Medical Campus
Steven E RobinsonUniversity of Colorado Anschutz Medical Campus
Phil F ChengUniversity of Zurich
Phil F ChengUniversity of Zurich
Rohith SrivasStanford University School of Medicine
Stephen SoonthornvacharinCancer Center, Sanford-Burnham Medical Research Institute
Trey Ideker (CM4AI)University of California
Trey Ideker (CM4AI)University of California
Marcus BosenbergYale School of Medicine
Rene GonzalezUniversity of Colorado Anschutz Medical Campus
William A RobinsonUniversity of Colorado Anschutz Medical Campus
William A RobinsonUniversity of Colorado Anschutz Medical Campus
Sumit K ChandaCancer Center, Sanford-Burnham Medical Research Institute
Carl F WareCancer Center, Sanford-Burnham Medical Research Institute
Reinhard DummerUniversity of Zurich
Reinhard DummerUniversity of Zurich
Dave S B HoonJohn Wayne Cancer Institute
Dave S B HoonJohn Wayne Cancer Institute
John M KirkwoodUniversity of Pittsburgh Cancer Center
Ze'ev RonaiCancer Center, Sanford-Burnham Medical Research Institute
Ze'ev RonaiCancer Center, Sanford-Burnham Medical Research Institute
  • 1 - 28

Datasets